Regression
Gene: SLC20A2
Over 50 families reported. Affected individuals can either be asymptomatic or show a wide spectrum of neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, ataxia, dementia, psychosis, seizures, and chronic headache. This is a progressive neurological disorder but typical age of onset is 30-50 years, and as such it does not typically cause neurodevelopmental regression.Created: 10 Sep 2020, 4:29 a.m. | Last Modified: 10 Sep 2020, 4:29 a.m.
Panel Version: 0.150
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Basal ganglia calcification, idiopathic, 1, MIM# 213600
Publications
Gene: slc20a2 has been classified as Red List (Low Evidence).
Phenotypes for gene: SLC20A2 were changed from to Basal ganglia calcification, idiopathic, 1, MIM# 213600
Publications for gene: SLC20A2 were set to
Mode of inheritance for gene: SLC20A2 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Mode of inheritance for gene: SLC20A2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Gene: slc20a2 has been classified as Red List (Low Evidence).
gene: SLC20A2 was added gene: SLC20A2 was added to Regression_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: SLC20A2 was set to Unknown